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Drug transporters have been widely studied in cancer cells, mostly due to their 
importance in drug resistance. Given their clinical relevance, the role of drug trans-
porters in chemotherapy-induced peripheral neurotoxicity (CIPN) is of particular 
interest, but knowledge is largely incomplete in dorsal root ganglia (DRG) sensory 
neurons. This critical aspect of CIPN has never been addressed until the observation 
in a single in vivo study that copper transporters are present and active in rat DRG 
neurons [1]. However, evidence is still missing regarding several crucial aspects of 
drug transporters, such as i) the possible co-localization of more than one transporter, 
ii) their relevance to each class of neurotoxic drugs, iii) their functionality and iv) the 
possibility to reduce toxicity through their pharmacological modulation in vivo.
The precise mechanisms of cellular uptake of DNA-intercalating platinum drugs 
are partly unknown, although it is commonly supposed that both passive diffusion 
as well as facilitated or active transport mechanisms play substantial roles. Cisplatin 
transporters suggested to be involved in modulation of platinum accumulation are 
MRP2, the copper transporters CTR1, ATP7A and ATP7B. Moreover, a recent notion 
is that various anticancer drugs can enter mammalian cells by facilitated transport 
via solute carriers (SLCs). Among all the SLCs transporters, organic cationic trans-
porter 2 (OCT2) is a critical determinant in the uptake and cytotoxicity of cisplatin 
in non-neuronal cells, and its activity modulation has been associated with reduced 
toxicity [2].
The antitubulin alkaloid paclitaxel is a substrate of the energy-dependent drug 
efflux pump P-glycoprotein (P-gp). P-gp is a member of the ATP-binding cassette 
(ABC) family of transporters widely expressed in many human cancers and the 
enhanced efflux of paclitaxel has been observed in drug-resistant tumor cells that 
overexpress P-gp. The role of P-gp in paclitaxel efflux has been confirmed by employ-
ing membrane modulating agents (such as verapamil and cyclosporin A) in combina-
tion with paclitaxel. The distribution of this transporter in the central nervous system 
is well known, but it has never been investigated in peripheral neurons [1]. Recently, 
paclitaxel has also been recognized as a substrate for the copper transporter ATP7A. 
The proteasome inhibitor bortezomib has only recently been described to be a sub-
strate of ABCG2, another member of the ABC family, but only in human leukemia cells. 
Other cellular transportes might also be implicated in neuronal damage in CIPN. 
We recently performed a thorough investigation on glutamate transporters derived 
from the observation that glutamate production inhibition reduced in rat models the 
neurotoxicity of cisplatin, paclitaxel and bortezomib [3]. We demonstrated the pres-
ence in the DRG of the transporters, their functionality and the possibility to mod-
ulate this functionality using pharmacological inhibitors (DL-threo- -hydroxy-aspar-
tate, dihydrokainate and L-serine-O-sulfate) in in vitro neuronal systems [4,5].
9Preliminary results have already been obtained regarding OCT2 demonstrating 
the presence at the mRNA level and the possibility to modulate in vitro cisplatin 
cytotoxicity in DRG neurons using the transporter competitor cimetidine. 
Based on these observations, the possible role of the different families of drug 
transporters and their possible relevance to CIP onset and severity will be here 
revised.
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